⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Leading Mental Health Researchers and Advocates to Be Honored at Premier Suicide Prevention Gala on May 7
prnewswire.com
JNJ
Distalmotion Secures Strategic Investment to Advance ASC Expansion of the DEXTER® Robotic Surgery System
globenewswire.com
JNJ
Outset Medical Reports Unaudited Fourth Quarter and 2025 Results
globenewswire.com
OM
ATRC
EMBC
HSIC
BSX
JNJ
Anumana Appoints Kevin Ballinger and Jean-Luc Butel to Board of Directors
businesswire.com
CVRX
TAK
ICON
RANI
BAX
MDT
BDX
JNJ
Biomedical and ICT Convergence Market Research Report 2025-2030: Opportunities in Developing Connected Medical Devices, Enhancing Precision Medicine, and Improving Healthcare Delivery
globenewswire.com
ABT
AMGN
ADI
AZN
BIIB
BIO
XRAY
GEHC
GILD
HON
JNJ
MDLZ
MRK
NVS
NVO
NXPI
PFE
SNY
SWX
STM
TEI
TXN
TMO
ZBH
FMS
JBL
LMT
MDT
ON
PHI
SYK
WMT
CES 2026: El futuro está aquí USA - español USA - English India - English USA - Français USA - Deutsch Korea - 한국어 APAC - Traditional Chinese Japan - Japanese
prnewswire.com
AMD
INTC
QCOM
CAT
AMZN
META
GOOG
MSFT
RBLX
UBER
LYFT
NVDA
IBM
MU
AVGO
AMAT
MRVL
ADBE
NFLX
CHTR
SIRI
SNAP
TTD
ROKU
XPER
ABT
BIIB
BMY
GILD
JNJ
MRK
PFE
GOOGL
ORCL
CRM
CSCO
ACN
BABA
JD
SONY
DE
OSK
HPQ
DELL
Over The Counter (OTC) Drugs Market is expected to generate a revenue of USD 367.08 Billion by 2032, Globally, at 8.10% CAGR: Verified Market Research®
globenewswire.com
JNJ
BHC
GSK
NVS
RYBREVANT® (amivantamab-vmjw) longer-term results show promising and durable responses in difficult-to-treat colorectal cancer
prnewswire.com
JNJ
Rejuvacare Ozempatch Ingredients Investigated: 2026 Consumer Analysis Examines Herbal Patch Formulation Disclosures
globenewswire.com
JNJ
LLY
Muscle Relaxant Drugs Market is expected to generate a revenue of USD 6.59 Billion by 2031, Globally, at 5.4% CAGR: Verified Market Research®
globenewswire.com
JNJ
ABBV